Immunotherapy combination shows benefit for patients with advanced melanoma
2021-05-20
(Press-News.org) Fixed-dose combination of nivolumab and relatlimab holds the cancer in check significantly longer than nivolumab alone
This is the first regimen to demonstrate a statistical benefit over anti-PD-1 monotherapy in metastatic melanoma
BOSTON - A combination of two drugs that target different proteins on immune system T cells kept advanced melanoma in check significantly longer than one of the drugs alone in a phase 3 clinical trial involving 714 patients. Dana-Farber Cancer Institute investigators co-led the study. Findings will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, being held virtually June 4-8, 2021, and are included in the ASCO press program.
The trial, known as the RELATIVITY-047 study, compared the effectiveness of the drug nivolumab, an immune checkpoint inhibitor, by itself against a combination of the LAG-3 blocking antibody relatlimab and nivolumab given as a fixed-dose. Trial participants who received the combination therapy as their initial treatment had a median progression-free survival - the time in which the disease did not worsen - of 10.1 months, compared to 4.6 months for those treated with nivolumab alone, investigators found. Twelve months after treatment, 47.7% of patients treated with the two-drug regimen had no advance of their disease, compared to 36% of those who received only nivolumab. The side effects of the combination were generally manageable.
Both nivolumab and relatlimab are antibody drugs. They target separate proteins on T cells to revive and reinvigorate the cells' natural attack on tumor cells. Nivolumab targets PD-1, a checkpoint protein that prompts T cells to call off their attack when it binds to a corresponding protein on tumor cells. Relatlimab targets the protein LAG-3, an immune checkpoint receptor protein that functions to control T-cell response, activation and growth.
"Immune checkpoint inhibitors such as nivolumab have revolutionized the treatment of patients with advanced melanoma," said F. Stephen Hodi, MD, the director of the Melanoma Center and the Center for Immuno-Oncology at Dana-Farber and the co-senior author of the study.
"However, novel combinations of checkpoint inhibitors with other immune agents are needed to improve results. The RELATIVITY trial is the first study of a combination treatment to demonstrate a clinically important benefit by simultaneously inhibiting the LAG-3 and PD-1 pathways."
INFORMATION:
The clinical trial was supported by Bristol Myers Squibb.
Relatlimab (RELA) + nivolumab (NIVO) versus NIVO in first-line advanced melanoma: Primary phase 3 results from RELATIVITY-047 (CA224-047) (abstract 9503) will be presented virtually during the Melanoma/Skin Cancers Oral Abstract Session on Sunday, June 6, 2021, 8:00am-11:00am.
For all ASCO-related media inquiries, call or email Victoria Warren, 617-939-5531, Victoria_Warren@dfci.harvard.edu. Follow the meeting live on Twitter using the hashtag #ASCO21 and follow Dana-Farber on Twitter at @DanaFarberNews.
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is one of the world's leading centers of cancer research and care. Dana-Farber's mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. The Institute provides the latest treatments in cancer for adults through Dana-Farber/Brigham and Women's Cancer Center and for children through Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dana-Farber is the only hospital nationwide with a top 6 U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care.
As a global leader in oncology, Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world, offering more than 1,100 therapeutic and non-therapeutic clinical trials.
ELSE PRESS RELEASES FROM THIS DATE:
2021-05-20
HOUSTON -- The glutaminase (GLS1) inhibitor IACS-6274, discovered and developed by The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division, appears to be well-tolerated with successful target inhibition and early signs of anti-tumor activity in a biomarker-driven Phase I trial. Interim results of the study will be presented at the 2021 American Society for Clinical Oncology (ASCO) Annual Meeting on June 4.
On the trial, 17 of 20 evaluable patients achieved a best response of stable disease, with a disease control rate of 60% at 12 weeks. Six patients with biomarker-defined advanced cancers ...
2021-05-19
URBANA, Ill. - Women's ability to work as entrepreneurs can help alleviate poverty and malnutrition in developing countries. As local governments and development organizations aim to encourage business opportunities, it's important to identify projects suited for women's lives in rural households.
The soy kit, which includes common household items such as a pot, spoon, thermometer, and cheese cloth, enables entrepreneurs to create value-added products from soy in small-scale household settings. The kit has potential to improve the economic conditions of Malawi women in a sustainable way, a University of Illinois study concludes.
"The larger issue is about adding value to agricultural products in the developing world as a means ...
2021-05-19
Boulder, Colo., USA: The Paleozoic era culminated 251.9 million years ago in the most severe mass extinction recorded in the geologic record. Known as the "great dying," this event saw the loss of up to 96% of all marine species and around 70% of terrestrial species, including plants and insects.
The consensus view of scientists is that volcanic activity at the end of the Permian period, associated with the Siberian Traps Large Igneous Province, emitted massive quantities of greenhouse gases into the atmosphere over a short time interval. This caused a spike in global temperatures and a cascade of other deleterious ...
2021-05-19
Keto, gluten-free, organic: If a pet owner is on a specific diet, chances are their dog is on it, too, a new U of G study reveals.
But when it comes to a grain-free diet, owners seem to choose it more for their dogs than themselves, the study also found.
"It demonstrates that many variables, not just dietary habits, influence the selection of dog food," said study lead author Sydney Banton, a master's student in U of G's Department of Animal Biosciences.
The international Pet Food Consumer Habit Survey is the first of its kind to examine factors involved in ...
2021-05-19
NEWPORT, Ore. - The population of white sharks that call the Central California coast their primary home is holding steady at about 300 animals and shows some signs of growth, a new long-term study of the species has shown.
Between 2011 and 2018, researchers were able to identify hundreds of individual adult and subadult white sharks, which are not fully mature but are old enough to prey on marine mammals. They used that information to develop estimates of the sharks' abundance.
"The finding, a result of eight years of photographing and identifying individual ...
2021-05-19
In new research, Texas A&M University scientists have for the first time revealed a single microscopic defect called a "twin" in a soft-block copolymer using an advanced electron microscopy technique. This defect may be exploited in the future to create materials with novel acoustic and photonic properties.
"This defect is like a black swan -- something special going on that isn't typical," said Dr. Edwin Thomas, professor in the Department of Materials Science and Engineering. "Although we chose a certain polymer for our study, I think the twin defect will be fairly universal across a bunch of similar soft matter systems, like oils, surfactants, biological materials and natural polymers. Therefore, our findings will be valuable to diverse research across the soft matter field."
The ...
2021-05-19
Scanning technology aimed at detecting small amounts of nuclear materials was unveiled by scientists in Sweden today, with the hope of preventing acts of nuclear terrorism.
Bo Cederwall, a professor of physics at KTH Royal Institute of Technology, says the technology can be used in airports and seaports for routine inspection of passengers and goods. The research is published and featured in the journals Science Advances and Science, respectively.
A form of tomography, the system enables quick 3D imaging of the source of neutron and gamma ray emissions from weapons-grade plutonium and other special nuclear materials, Cederwall says.
The so-called Neutron-Gamma Emission Tomography (NGET) system goes beyond the capabilities of existing radiation portal monitors, ...
2021-05-19
Despite expert recommendations that children continue to get regularly scheduled vaccines during the pandemic, vaccination rates have decreased in several states.
A new study by researchers from the Texas A&M University School of Public Health and several other research institutions looked at childhood immunization rates in Texas to see what effect the COVID-19 pandemic may have had on childhood immunizations in 2020. In the study, led by public health doctoral student Tasmiah Nuzhath and published in the journal Vaccine, the researchers used data from a statewide immunization registry ...
2021-05-19
May 19, 2021 - For patients with severe arthritis of the ankle, total ankle arthroplasty (TAA) provides better long-term function than ankle arthrodesis (AA), reports a study in The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.
"Both established treatments for end-stage ankle arthritis are effective at pain relief and improved patient-reported outcomes," according to the research by Bruce Sangeorzan MD, and colleagues at the University of Washington and VA Puget Sound Health Care System. "However, it appears TAA leads to greater improvement in most patient-reported outcome measures at 48 months after surgery."
Study adds to evidence supporting TAA for ankle arthritis
End-stage ankle arthritis is characterized ...
2021-05-19
The continued growth of wireless and cellular data traffic relies heavily on light waves. Microwave photonics is the field of technology that is dedicated to the distribution and processing of electrical information signals using optical means. Compared with traditional solutions based on electronics alone, microwave photonic systems can handle massive amounts of data. Therefore, microwave photonics has become increasingly important as part of 5G cellular networks and beyond. A primary task of microwave photonics is the realization of narrowband filters: the selection of specific data, at specific frequencies, out of immense volumes that are carried over light.
Many microwave photonic systems are built ...
LAST 30 PRESS RELEASES:
[Press-News.org] Immunotherapy combination shows benefit for patients with advanced melanoma
